Subscribe to our Newsletters !!
Anemones Sea have a striking beauty and the abilit
Simply put, without a safety culture, your lab wil
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
Potassium cyanide is infamous in the world for the
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
AstraZeneca Plc said on Friday clinical trials of its experimental COVID-19 vaccine declared in Japan, while adding that it was in talks with regulators on data necessary to restart studies in the United States, where they remain halted.
Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. Although most trials have resumed, U.S. trials continue to be on pause as regulators widened their probe, Reuters reported on Wednesday.
While most trials have resumed, U.S. trials are still on pause as regulators widened their probe, Reuters reported on Wednesday.
The British drugmaker said the early-to-mid-stage trial for the vaccine candidate against the novel coronavirus resumed in Japan after consultations with the federal health regulator, the Japanese Pharmaceuticals and Medical Devices Agency.
Trials in Britain, Brazil, South Africa and India had already declared.
